SCHEMBL56190

SCHEMBL56190

C1[N]O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Sulfide SCHEMBL289335 0.38
Hydrogen Sulfide SCHEMBL4780776 0.38
SCHEMBL29771483 0.38
SCHEMBL8949676 0.38
Hydrogen Sulfide SCHEMBL15941638 0.38
Xenon Xe 127 SCHEMBL29617516 0.38
SCHEMBL29375394 0.38
SCHEMBL1650927 0.38
SCHEMBL15913 0.38
SCHEMBL4595145 0.38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426182-B1 METHODS AND COMPOSITIONS FOR DENTAL TISSUE REPAIR AND/OR REGENERATION HARVARD COLLEGE (US) 2024-05-01 EP claimed
EP-3356345-B1 HETEROARYL DERIVATIVES AS SEPIAPTERIN REDUCTASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2023-11-08 EP claimed
US-11590197-B2 Agents targeting inhibitor of apoptosis proteins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-02-28 US claimed
EP-3430017-B1 COMPOSITIONS AND METHODS FOR TREATING PARASITIC DISEASES UNIV CALIFORNIA (US) 2023-01-25 EP claimed
EP-3405465-B1 IRAK4 INHIBITING AGENTS BIOGEN MA INC (US) 2021-10-13 EP claimed
US-20210198235-A1 DERIVATIVES OF PIPERLONGUMINE AND USES THEREOF AURANSA INC. 2021-07-01 US claimed
US-20210188804-A1 NOVEL POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2021-06-24 US claimed
US-20210188809-A1 IRAK4 INHIBITING AGENTS BIOGEN MA INC. 2021-06-24 US claimed
CN-112930337-A Antiproliferative phenoxy (hetero) aryl ethers 赛尼欧普罗有限责任公司 2021-06-08 CN claimed
CN-112888479-A Aromatic molecules for the treatment of pathological conditions 赛尼欧普罗有限责任公司 2021-06-01 CN claimed
US-20110105532-A1 Haloalkyl-substituted amides as insecticides and acaricides BAYER CROPSCIENCE AG (DE) 2011-05-05 US claimed
EP-1836165-A4 DIPYRROLE COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCER OR VIRAL DISEASES GEMIN X PHARMACEUTICALS CANADA (CA) 2009-07-08 EP claimed
US-20080280896-A1 Dipyrrole Compounds, Compositions, and Methods For Treating Cancer or Viral Diseases GEMIN X BIOTECHNOLOGIES INC. (CA) 2008-11-13 US claimed
EP-1836165-A1 DIPYRROLE COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCER OR VIRAL DISEASES Gemin X Biotechnologies Inc. (CA) 2007-09-26 EP claimed
US-20070179122-A1 Beta-Aminoacid-Derivatives As Factor Xa Inhibitors SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-08-02 US claimed
WO-2006069441-A1 DIPYRROLE COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCER OR VIRAL DISEASES GEMIN X BIOTECHNOLOGIES INC. (CA) 2006-07-06 WO claimed
EP-1658081-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA Bioscience nv (BE) 2006-05-24 EP claimed
WO-2005021003-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA BIOSCIENCE NV (BE) 2005-03-10 WO claimed
US-20040077859-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2004-04-22 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed